KYLIE MEYER: Open Payments
NPI 1154941011 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 29 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $301 · 2025 $482
Food & beverage: $482
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 15 | $195 |
| SK Life Science, Inc. | 2 | $60 |
| JAZZ PHARMACEUTICALS INC. | 2 | $48 |
| UPSHER-SMITH LABORATORIES LLC | 1 | $29 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $26 |
| Aucta Pharmaceuticals, Inc. | 4 | $25 |
| Zimmer Biomet Holdings, Inc. | 1 | $25 |
| Otter Pharmaceuticals, LLC | 1 | $20 |
Products named: Fintepla, EPIDIOLEX, TORPENZ, FYCOMPA, BOTOX, Nayzilam, Motpoly XR, ROSA.
Industry payments across MI — which companies pay providers there.
